Peer-reviewed articles
A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers
Efficacy and safety of Seladelpar in the treatment of primary biliary cholangitis: a systematic review and meta-analysis
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results
PBC-HOPE: A randomized controlled trial of hypnosis and psychoeducation in women with primary biliary cholangitis and fatigue
Primary biliary cholangitis: Personalizing second-line therapies
Primary Biliary Cholangitis in 2025: A New Frontier
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis
© 2025 Wolters Kluwer. All right reserved.